Lawrence Otto Klein serves as Executive at CRISPR Therapeutics AG, where they oversee executive responsibilities. Since joining the company, Lawrence Otto Klein has executed 58 insider transactions totaling $26.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 11, 2020 involved selling 682 shares valued at $41.6K.
Lawrence Otto Klein currently holds 306,700 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence Otto Klein has been a net seller of CRSP stock. They have purchased $0 and sold $26.0M worth of shares.
Lawrence Otto Klein's most recent insider trade was on May 11, 2020, when they sold 682 shares at $61.07 per share.
Get notified when new Form 4 filings are submitted
| $60.38 |
| Discretionary |
| May 11, 2020 | CRSP | $146.5K | Option Exercise | 25,000 | $5.86 | Discretionary |
| Jul 11, 2019 | CRSP | $421.1K | Sale | 8,421 | $50.01 | Discretionary |
| Jul 11, 2019 | CRSP | $49.3K | Option Exercise | 8,421 | $5.86 | Discretionary |
| Jul 10, 2019 | CRSP | $67.9K | Option Exercise | 11,579 | $5.86 | Discretionary |
| Jul 10, 2019 | CRSP | $579.2K | Sale | 11,579 | $50.02 | Discretionary |
| Jan 2, 2019 | CRSP | $597.4K | Award | 20,000 | $29.87 | Discretionary |